In our AML cohort, top-ranked genes showed convergence of cohort signal, essentiality, and pathway coherence; several understudied genes (AGTR2, NTRK1, LAG3, MPL, TERT) retained high priority after safety filtering, highlighting actionable and novel avenues for experimental validation. This evidence concerns the gene MPL and acute myeloid leukemia.